Global Nuclear Medicine Science Market Growth (Status and Outlook) 2025-2031

The global Nuclear Medicine Science market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Nuclear medicine science uses radioactive material inside the body to see how organs or tissue are functioning (for diagnosis) or to target and destroy damaged or diseased organs or tissue (for treatment).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Nuclear Medicine Science Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Science sales in 2024, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Science sales for 2025 through 2031. With Nuclear Medicine Science sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Science industry.

This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Science landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclear Medicine Science portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Science market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Science and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Science.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Science market by product type, application, key players and key regions and countries.

Segmentation by Type:
Radioisotopes
Medical Isotopes

Segmentation by Application:
Hospitals
Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NTP Radioisotopes
Medical Isotopes
ITM
Cambridge Isotope Laboratories
CMR
Urenco
Northwest Medical Isotopes
SHINE Medical

Please note: The report will take approximately 2 business days to prepare and deliver. Show more